MINNEAPOLIS, Sept. 24,
2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:
TECH) today announced it will showcase its portfolio of solutions
advancing neuroscience research at the upcoming annual meeting of
the Society for Neuroscience (SfN) at Neuroscience 2024, taking
place October 5-9, 2024, in
Chicago, Illinois.
At booth #1165, Bio-Techne will feature its market-leading
portfolio of high-quality life science reagents, immunoassays,
automated proteomic analytical instruments, and multiomics
solutions. These technologies are accelerating research by
streamlining biomarker discovery and quantification, optimizing
neural cell cultures and organoid models, and transforming drug
discovery and screening processes.
In a nanosymposium, Bio-Techne will discuss a study
investigating senescence in the aging brain, highlighting the novel
RNAscope™ Multiomic LS assay for high-throughput spatial analysis.
Additionally, the team will present a poster detailing Bio-Techne's
commitment to antibody validation for use on COMETTM,
the fully automated, high-throughput, hyperplex spatial biology
platform from LunaphoreTM, a Bio-Techne brand.
Bio-Techne will also host a Product Theater presentation in
collaboration with FUJIFILM Cellular Dynamics, Inc. The
presentation will focus on intracellular signaling in Alzheimer's
disease, including the use of Simple Western™ automated western
technology for protein size characterization and quantification
directly in complex samples like cell and tissue lysates. This
technology will be further highlighted in a poster presentation
from Cell Signaling Technology, demonstrating its use in
characterizing iPSC-derived microglial activation.
"We are proud to support the advancement of neuroscience
research with our portfolio of innovative proteomic research tools,
research reagents, and spatial biology solutions," said
Kim Kelderman, Bio-Techne's
President and Chief Executive Officer. "Scientists rely on our
suite of cutting-edge solutions to further the understanding of
neuroscience and other biological processes, enabling the
development of next-generation therapies and treatments. We are
looking forward to showcasing our solutions at this important
conference."
To learn more about Bio-Techne's activities at Neuroscience
2024, visit https://www.bio-techne.com/about/events/SfN.
Bio-Techne Speaker Presentations:
Simple Western™ Capillary Immunoassays: A Game Changer in
Elucidating Intracellular Signaling in Alzheimer's
Disease
Monday, October 7 at
2:30pm
Presenters: Scott Schachtele, PhD,
Product Manager, Neuroscience, FUJIFILM Cellular Dynamics
Charles Haitjema, Senior Research
Area Manager, Analytical Solutions Division, Bio-Techne
Location: Exhibit Hall, Aisle 900, Product Theater 1
Investigating Hallmarks of Senescence in the Aging Brain
Using a Novel RNA-Protein Multiomic Co-Detection
Assay
Wednesday, October 9,
3:00pm - 3:15pm
Presenter: Debia Wakhloo, PhD, Application Scientist, Marketing
Location: MCP Room S106
Bio-Techne Poster Presentations: An Automated Assay
for Precise and Sensitive Quantification of pTau217 in Plasma and
Cerebrospinal Fluid
Sunday, October
6, 3:00pm – 4:00pm
Presenter: Yoav Noam, PhD, Senior
Manager, Research & Development
Poster Session: LBA003 – Theme C, Late Breaking Posters
Abstract: 13849
Bridging the Gap in Synaptic Research: Visualizing Neurexin
and Neuroligin Interactions Using Multiomic RNAscope
Technology
Sunday, October 6,
1:00pm – 2:00pm
Presenter: Debia Wakhloo, PhD, Application Scientist,
Marketing
Poster Session: PSTR143 – Biochemical and Molecular Technologies
I
Abstract: 5821
Spatial Multiomic Assay for Studying Interneuron
Heterogeneity in the Brain
Tuesday,
October 8, 3:00pm –
4:00pm
Presenter: Anushka Dikshit, PhD, Senior Manager,
Applications
Poster Session: LBA009 – Theme I, Late Breaking Posters
Abstract: 13972
Evaluation of IDH1, EGFR, IGF1R and Ki67 Biomarkers in
Glioblastoma using Lunaphore COMET™ Platform
Wednesday, October 9, 2:00pm - 3:00pm
Presenter: Alexander Kalyuzhny, PhD,
Sr. Manager, Antibody Validation
Poster Session: PSTR444 - Glioblastoma and Other Nervous System
Cancers: Mechanisms and Techniques
Abstract: 10867
Poster Presentation, In Collaboration:
Characterization of iPSC-Derived Human Microglial Activation
Using Automated, Multiplex Capillary Western Blot Analysis
Sunday, October 6, 10:00am - 11:00am
Presenter: Richard Cho, PhD,
Associate Director, Neuroscience, Cell Signaling Technology
Poster Session: PSTR058 - In Vitro Modeling of
Neuroinflammation and Neurodegeneration
Abstract: 8455
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH)
is a global life sciences company providing innovative tools and
bioactive reagents for the research and clinical diagnostic
communities. Bio-Techne products assist scientific investigations
into biological processes and the nature and progress of specific
diseases. They aid in drug discovery efforts and provide the means
for accurate clinical tests and diagnoses. With hundreds of
thousands of products in its portfolio, Bio-Techne generated
approximately $1.2 billion in net sales in fiscal 2024 and has
approximately 3,100 employees worldwide. For more information on
Bio-Techne and its brands, please
visit http://www.bio-techne.com or follow the Company on
social media
at Facebook, LinkedIn, Twitter or YouTube.
About Bio-Techne Corporation (NASDAQ: TECH)
Contact: David Clair, Vice President, Investor Relations &
Corporate Development
david.clair@bio-techne.com
612-656-4416
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-neuroscience-2024the-society-for-neuroscience-sfn-annual-meeting-302244769.html
SOURCE Bio-Techne Corporation